Tomer Kariv Net Worth & Insider Trades

Tomer Kariv - Director, Keros Therapeutics, Inc

As of June 8, 2023

What is Tomer Kariv's Net Worth?

The current estimated net worth of Keros Therapeutics, Inc's Director, Tomer Kariv, is estimated to be about $23.22M . Tomer Kariv owns about 155,262 units of Keros Therapeutics, Inc common stock. In the last 3 years at Keros Therapeutics, Inc, Tomer Kariv has sold an estimated value of $0.72 worth.

What is Tomer Kariv's Past Insider Trading?

Tomer Kariv's largest purchase order was 3,982,599 units , worth over $7M on April 13, 2020. In total, Tomer Kariv has made about 6 transactions over 3 years of their time at Keros Therapeutics, Inc. Tomer Kariv usually trades in June, with the busiest year in 2020 and 2022. The most recent transaction was a purchase order of 60,000 units , worth over $3M on November 19, 2020.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Tomer Kariv's' Mailing Address?

  • Mailing address is C/o Arno Therapeutics, Inc. 200 Route 31 North, Suite 104 Flemington NJ 08822 NJ

Keros Therapeutics, Inc Executive Compensation

Name
Year
Salary
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Jasbir Seehra, Ph.D. 2020 $521,014 $8,713,137 $262,650 $3,498 $9,500,299
Jasbir Seehra, Ph.D. 2019 $485,100 $15,379 $194,040 - $694,519
Keith Regnante 2020 $323,170 $1,901,352 $138,000 $521 $2,363,042
Jennifer Lachey, Ph.D. 2020 $370,196 $3,017,362 $154,200 $521 $3,542,278
Jennifer Lachey, Ph.D. 2019 $294,255 $27,039 $93,000 - $414,294
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1664710/000110465921051967/tm2112429-1_def14a.htm

What are Keros Therapeutics, Inc's Past Insider Trades?

Keros Therapeutics, Inc's most recent insider trade came on June 12, 2023 by Keith Regnante who sold 40,000 units worth $1.86M . In the last 3 years, insiders at Keros Therapeutics, Inc have sold an estimated value of $37.33M and bought an estimated value of $46.93M worth of shares. Insider trading is most common in June, with the busiest year in 2021. The most active traders at the company are Jennifer Lachey, Chief Scientific Officer,  Julius Knowles, Director,  and Claudia Ordonez, Chief Medical Officer .

Keros Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...